首页> 外文OA文献 >LB0011 A PHASE II SINGLE ARM (ADAPTIVE DESIGN) TRIAL OF TOCILIZUMAB IN ANTI-TNF REFRACTORY PATIENTS WITH JIA-ASSOCIATED UVEITIS (APTITUDE TRIAL)

【2h】

LB0011 A PHASE II SINGLE ARM (ADAPTIVE DESIGN) TRIAL OF TOCILIZUMAB IN ANTI-TNF REFRACTORY PATIENTS WITH JIA-ASSOCIATED UVEITIS (APTITUDE TRIAL)

机译：LB0011 A II期单臂（Adaptive Design）试验在均匀葡萄炎（Aptitude试验）中的抗TNF耐火患者中的抗TNF耐火患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Athimalaipet Ramanan; Andrew DickDick; Ashley JonesJones; Andrew MckayMckay; Catherine GulyGuly; Ben HardwickHardwick; Richard LeeLee; Matthew SmythSmyth; Michael BeresfordBeresford;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial) [J] . Athimalaipet V. Ramanan, Andrew D. Dick, Ashley P. Jones, BMC Rheumatology . 2018,第1期

机译：Tocilizumab在抗TNF难治性JIA相关性葡萄膜炎患者中的II期试验方案（APTITUDE试验）
2. Four‐year follow‐up of a single arm, phase II II clinical trial of ibrutinib with rituximab ( IR IR ) in patients with relapsed/refractory mantle cell lymphoma ( MCL MCL ) [J] . Jain Preetesh, Romaguera Jorge, Srour Samer A., British Journal of Haematology . 2018,第3期

机译：单臂的四年随访，II期II II II临床试验与Rituximab（IR IR）复发/难治性地幔细胞淋巴瘤（MCL MCL）的患者
3. Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial [J] . Nut Koonrungsesomboon, Nuttapong Ngamphaiboon, Natavudh Townamchai, BMC Cancer . 2020,第1期

机译：II期，多中心，开放标签，单臂临床试验评估霉酚酸酯Mofetil在高级局部晚期或转移性骨肉瘤（ESMMO）患者中的疗效和安全性：理论和设计的ESMMO试验
4. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
5. Optimal Designs for Two-Arm Randomized Phase II Clinical Trials with Multiple Constraints. [D] . Jiang, Wei. 2014

机译：具有多个约束的两臂随机II期临床试验的优化设计。
6. A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial) [O] . Athimalaipet V. Ramanan, Andrew D. Dick, Ashley P. Jones, 2018

机译：Tocilizumab在抗TNF难治性JIA相关性葡萄膜炎患者中的II期试验方案（APTITUDE试验）
7. Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial [O] . Athimalaipet V Ramanan, Andrew D Dick, Catherine Guly, 2020

机译：在抗TNF难治性少年特发性关节炎患者中与核毒素相关葡萄炎（Aptitude）：多期，单臂，第2期试验

LB0011 A PHASE II SINGLE ARM (ADAPTIVE DESIGN) TRIAL OF TOCILIZUMAB IN ANTI-TNF REFRACTORY PATIENTS WITH JIA-ASSOCIATED UVEITIS (APTITUDE TRIAL)

著录项

引文网络

相似文献

相关主题

期刊订阅